title: Coexistence of borderline tuberculoid Hansen's disease with tuberculosis verrucosa cutis in a child--a rare case.
abstract: M. leprae is a more prevalent cause of cutaneous infections as compared M. tuberculosis, though both belong to the same family of organisms; their co-existence is a rare entity in children. It has been suggested that cross-immunity exists between tuberculosis and leprosy with reports of BCG vaccine giving some protection against leprosy. In spite of epidemiological, clinical and microbiological evidences; the exact relationship between tuberculosis and leprosy still remains unclear. It is imperative to rule out coexistence of cutaneous tuberculosis and leprosy as therapy with rifampicin in treatment of leprosy can lead to drug resistance in management of tuberculosis and the use of steroid in leprosy can aggravate cutaneous tuberculosis.
authors: Department of Dermatology, Jaya Jagadguru Murugharajendra Medical College (JJMC), Davangere-577 004, Karanataka, India.
authors: K
authors: K
authors: Ravindra
authors: Sugareddy
authors: T
authors: T
authors: Ramachander
mesh_terms: D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D001500:BCG Vaccine; D002648:Child; D024881:Drug Resistance, Bacterial; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D015439:Leprosy, Borderline / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D015441:Leprosy, Tuberculoid / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D012293:Rifampin / Q000627:therapeutic use; D014382:Tuberculosis, Cutaneous / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
chemical_list: D000904:Antibiotics, Antitubercular; D001500:BCG Vaccine; D007917:Leprostatic Agents; D012293:Rifampin